Attorney Advises Labs to Track Genetic Test LCDs

By Robert Michel | From the Volume XXIX, No. 13 – September 19, 2022 Issue

CEO SUMMARY: Skyrocketing numbers of genetic test referrals and telehealth claims since 2016 are getting the full attention of both federal prosecutors and auditors from Medicare and private health insurers. The DOJ has filed criminal cases against a growing number of telehealth pro…

Read More

---

Feds Target Genetic Test and Telemedicine Fraud

By Robert Michel | From the Volume XXIX, No. 13 – September 19, 2022 Issue

MEDICARE FRAUD TOTALING $562 MILLION in genetic and cardiovascular tests is at the heart of recent federal criminal cases involving telemedicine that names clinical laboratory owners, physicians, and healthcare marketers as defendants.  A host of indictm…

Read More

---

September 19, 2022 Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXIX, No. 13 – September 19, 2022 Issue

Déjà vu? Lawmakers in Congress question whether public health officials have done enough to stay ahead of monkeypox, including the availability of diagnostic tests. Concerns about such testing came up during a Sept. 14 hearing before the Senate’s Health, Education, Labor, and Pensions Committee. …

Read More

---

Balwani Guilty! Sentencing Is Next for Theranos Execs

By Robert Michel | From the Volume XXIX, No. 10 – July 18, 2022 Issue

CEO SUMMARY: The trial of former Theranos President and Chief Operating Officer Ramesh “Sunny” Balwani ended with convictions by a jury on 12 counts of wire fraud and conspiracy. Now all eyes are looking ahead to the sentencing of Balwani and Elizabeth Holmes, the founder and fo…

Read More

---

New Percentage-Based Commissions Ruling

By Robert Michel | From the Volume XXIX, No. 10 – July 18, 2022 Issue

CEO SUMMARY: In denying a motion to dismiss certain charges against a clinical laboratory owner, a federal court in California has declared that the Eliminating Kickbacks in Recovery Act (EKRA) of 2018 applies to payments for marketing to physicians and other referral sources. This …

Read More

---

Halfway Through 2022, More Changes Come at Labs

By R. Lewis Dark | From the Volume XXIX, No. 8 – June 6, 2022 Issue

APPROACHING THE MIDWAY MARK OF 2022, some clinical laboratory directors and pathologists might feel like they’ve already experienced enough changes to last the whole year.  For example, since the start of 2022, we’ve seen SARS-CoV-2 testing surges co…

Read More

---

DOJ Charges Execs over Alleged Lab Kickbacks to Obtain Restitution

By Robert Michel | From the Volume XXIX, No. 8 – June 6, 2022 Issue

CEO SUMMARY: Multiple executives and sales representatives at True Health Diagnostics and Boston Heart Diagnostics have been named as defendants in a civil suit filed by the U.S. Department of Justice. The complaint centers on alleged kickbacks in return for clinical laboratory test…

Read More

---

Labs Can Expect COVID-19 Lab Testing Audits and Federal Investigations

By Robert Michel | From the Volume XXIX, No. 7 – May 16, 2022 Issue

This is an excerpt of a 2,081-word article in the May 16, 2022 issue of  THE DARK REPORT. The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: Billions of federal dollars were paid out for needed SARS-CoV-2 testing during the pandemic. Now, even th…

Read More

---

Labs Can Expect COVID-19 Test Audits, Investigations

By Robert Michel | From the Volume XXIX, No. 7 – May 16, 2022 Issue

  CEO SUMMARY: Billions of federal …

Read More

---

DOJ: EKRA Governs Lab Sales and Marketing Commissions

By Robert Michel | From the Volume XXIX, No. 6 – April 25, 2022 Issue

BY FILING A MOTION IN A U.S. DISTRICT COURT RECENTLY, officials from the federal Department of Justice (DOJ) took steps to oppose an earlier ruling by a federal judge in Hawaii dealing with the way the Eliminating Kickbacks in Recovery Act of 2018 (EKRA) governs how percentage-based commission…

Read More

---